http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26865391

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 877
issn 0944-1174
1435-5922
issueIdentifier 8
pageRange 871-877
publicationName Journal of Gastroenterology
startingPage 871
bibliographicCitation Hass HG, Bock T, Nehls O, Kaiser S. Rapid HBV DNA decrease (week 12) is an important prognostic factor for first-line treatment with adefovir dipivoxil for chronic hepatitis B. Journal of Gastroenterology. 2009 May 21;44(8):871–7. doi: 10.1007/s00535-009-0078-y.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_02ad1ceff0831e294345760b97b1e26d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e1ba0362c710967a9b8c4a900e0fa74
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8bdbd20d3947be3cde888812fff4c39f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_804817a525fcb34c3f4fd32f73dc3be8
date 2009-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/19458896
https://doi.org/10.1007/s00535-009-0078-y
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2560
https://portal.issn.org/resource/ISSN/1435-5922
https://portal.issn.org/resource/ISSN/0944-1174
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title Rapid HBV DNA decrease (week 12) is an important prognostic factor for first-line treatment with adefovir dipivoxil for chronic hepatitis B
discusses http://id.nlm.nih.gov/mesh/M0006695
http://id.nlm.nih.gov/mesh/M0571031
http://id.nlm.nih.gov/mesh/M0000347
http://id.nlm.nih.gov/mesh/M0001518
http://id.nlm.nih.gov/mesh/M0000620
http://id.nlm.nih.gov/mesh/M0278180
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10398
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60871

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127945305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129046631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129613204

Total number of triples: 35.